Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis

Year: 2023

Type: article

Abstract: We examined changes in the proportion of people with human immunodeficiency virus (PWH) with virologic suppression (VS) in a multisite US cohort before and since the coronavirus disease 2019 (COVID-19) pandemic. Overall, prior gains in VS slowed during COVID-19, with disproportionate impacts on Black PWH and PWH who inject drugs.

Source: Clinical Infectious Diseases

DOI: 10.1093/cid/ciad657

Authors: Matthew A Spinelli, Katerina A Christopoulos, Carlos V Moreira, Jennifer P Jain, Nadra Lisha, David V Glidden, Greer A Burkholder, Heidi M Crane, Adrienne E Shapiro, Jeffrey M Jacobson, Edward R Cachay, Kenneth H Mayer, Sonia Napravnik, Richard D Moore, Monica Gandhi, Mallory O Johnson

Institutions: University of California, San Francisco, University of Alabama at Birmingham, University of Washington, Case Western Reserve University, University of California San Diego, Harvard University, Fenway Health, University of North Carolina at Chapel Hill, Johns Hopkins University

Language: English

Topic: HIV/AIDS Research and Interventions

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Gilead Sciences, Johns Hopkins University, Agence Nationale de Recherches sur le Sida et les Hépatites Virales, National Institutes of Health, Agency for Healthcare Research and Quality, National Heart, Lung, and Blood Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, Fogarty International Center, European and Developing Countries Clinical Trials Partnership, CHIST-ERA

OpenAlex ID: W4388667363